ClinicaliQ Trial Snapshot
- The Oxford Risk Factors And Non-Invasive Imaging Study — Recruiting • Cardiology / Cardiovascular • NCT05169333.
- What is being tested: ORFAN is developing and validating novel biomarkers for cardiometabolic disease risk by combining CT imaging data with biological material collection in a diverse patient cohort across multiple UK centres.
- Patient eligibility overview: This prospective observational study recruits a multi-ethnic cohort of participants to ensure biomarker findings are generalisable across different populations and risk profiles.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Eligibility Snapshot
- : Inclusion Criteria for study Arms 1, 2 and 3: * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 -99 years. Inclusion Criteria for study Arm 4: • Male or Female, aged 18 -99 years.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.